Naya, Ian P: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

The effect of zafirlukast on repetitive exercise–induced bronchoconstriction: The possible role of leukotrienes in exercise-induced refractoriness☆☆☆★

Dessanges, Jean-François, Préfaut, Christian, Taytard, André, Matran, Régis, Naya, Ian, Compagnon, Anne, Dinh-Xuan, A.Tuan

Journal:

Journal of Allergy and Clinical Immunology

Year:

1999

Language:

english

File:

PDF, 79 KB

english, 1999

2

Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol in Maintenance-Naïve Patients with Moderate Symptomatic Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis

Alcázar Navarrete, Bernardino, Boucot, Isabelle, Naya, Ian, Tombs, Lee, Lipson, David A., Compton, Chris, Sousa, Ana R., Feldman, Gregory

Journal:

Pulmonary Therapy

Year:

2018

Language:

english

File:

PDF, 457 KB

english, 2018

3

Improving science-policy interface: Lessons from the policy lab methodology in Nepal's community forest governance

Ojha, Hemant, Regmi, Udeep, Shrestha, Krishna K., Paudel, Naya Sharma, Amatya, Swoyambhu Man, Zwi, Anthony B., Nuberg, Ian, Cedamon, Edwin, Banjade, Mani R.

Journal:

Forest Policy and Economics

Year:

2019

Language:

english

File:

PDF, 757 KB

english, 2019

4

Treatment preferences of adolescent patients with asthma

Eugene G. Weinberg, Ian Naya

Journal:

Pediatric Allergy and Immunology

Year:

2000

Language:

english

File:

PDF, 105 KB

english, 2000

5

Post hoc analysis and claims of superiority in the excel trial

Ian P. Naya, Tomas L.G. Andersson

Journal:

Respiratory Medicine

Year:

2007

Language:

english

File:

PDF, 146 KB

english, 2007

6

Budesonide/formoterol maintenance and reliever therapy versus conventional best practice

Pascal Demoly, Renaud Louis, Ulrik Søes-Petersen, Ian Naya, Åsa Carlsheimer, Heinrich Worth, Joao Almeida, Malcolm R. Sears

Journal:

Respiratory Medicine

Year:

2009

Language:

english

File:

PDF, 567 KB

english, 2009

7

Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol

Pavord, Ian D., Jeffery, Peter K., Qiu, Yusheng, Zhu, Jie, Parker, Debbie, Carlsheimer, Åsa, Naya, Ian, Barnes, Neil C.

Journal:

Journal of Allergy and Clinical Immunology

Year:

2009

Language:

english

File:

PDF, 582 KB

english, 2009

8

Influence of zafirlukast and loratadine on exercise-induced bronchoconstriction

Dahlén, Barbro, Roquet, Annika, Inman, Mark D., Karlsson, Östen, Naya, Ian, Anstrén, Gudrun, O'Byrne, Paul M., Dahlén, Sven-Erik

Journal:

Journal of Allergy and Clinical Immunology

Year:

2002

Language:

english

File:

PDF, 137 KB

english, 2002

9

The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised, controlled studies with comparisons to standard therapy

Roland Buhl, Piotr Kuna, Matthew J Peters, Tomas LG Andersson, Ian P Naya, Stefan Peterson, Klaus F Rabe

Journal:

Respiratory Research

Year:

2012

Language:

english

File:

PDF, 490 KB

english, 2012

10

Prevalence and Burden of Dyspnoea Among Patients with Chronic Obstructive Pulmonary Disease in Five European Countries

Punekar, Yogesh Suresh, Mullerova, Hana, Small, Mark, Holbrook, Tim, Wood, Robert, Naya, Ian, Valle, Manuel

Journal:

Pulmonary Therapy

Year:

2016

Language:

english

File:

PDF, 941 KB

english, 2016

11

Triple Therapy of Umeclidinium + Inhaled Corticosteroids/Long-Acting Beta2 Agonists for Patients with COPD: Pooled Results of Randomized Placebo-Controlled Trials

Siler, Thomas M., Kerwin, Edward, Tombs, Lee, Fahy, William A., Naya, Ian

Journal:

Pulmonary Therapy

Year:

2016

Language:

english

File:

PDF, 698 KB

english, 2016

12

Bronchodilator reliever use and its association with the economic and humanistic burden of COPD: a propensity-matched study

Punekar, Yogesh Suresh, Naya, Ian, Small, Mark, Holbrook, Tim, Wood, Robert, Mullerova, Hana, Valle, Manuel

Journal:

Journal of Medical Economics

Year:

2016

Language:

english

File:

PDF, 1.61 MB

english, 2016

13

Rapid Silviculture Appraisal to Characterise Stand and Determine Silviculture Priorities of Community Forests in Nepal

Cedamon, Edwin, Nuberg, Ian, Paudel, Govinda, Basyal, Madan, Shrestha, Krishna, Paudel, Naya

Journal:

Small-scale Forestry

Year:

2017

Language:

english

File:

PDF, 946 KB

english, 2017

14

Assessing Short-term Deterioration in Maintenance-naïve Patients with COPD Receiving Umeclidinium/Vilanterol and Tiotropium: A Pooled Analysis of Three Randomized Trials

Maleki-Yazdi, M. Reza, Singh, Dave, Anzueto, Antonio, Tombs, Lee, Fahy, William A., Naya, Ian

Journal:

Advances in Therapy

Year:

2016

Language:

english

File:

PDF, 700 KB

english, 2016

15

From Forests to Food Security: Pathways in Nepal’s Community Forestry

Karki, Rahul, Shrestha, Krishna K., Ojha, Hemant, Paudel, Naya, Khatri, Dil B., Nuberg, Ian, Adhikary, Anukram

Journal:

Small-scale Forestry

Year:

2017

Language:

english

File:

PDF, 1022 KB

english, 2017

16

Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study

Feldman, Gregory J., Sousa, Ana R., Lipson, David A., Tombs, Lee, Barnes, Neil, Riley, John H., Patel, Sadhana, Naya, Ian, Compton, Chris, Alcázar Navarrete, Bernardino

Journal:

Advances in Therapy

Year:

2017

Language:

english

File:

PDF, 906 KB

english, 2017

17

A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD

Sion, Katya Y. J., Huisman, Eline L., Punekar, Yogesh S., Naya, Ian, Ismaila, Afisi S.

Journal:

Pulmonary Therapy

Year:

2017

Language:

english

File:

PDF, 850 KB

english, 2017

18

Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective

Shah, Dhvani, Driessen, Maurice, Risebrough, Nancy, Baker, Timothy, Naya, Ian, Briggs, Andrew, Ismaila, Afisi S.

Journal:

Cost Effectiveness and Resource Allocation

Year:

2018

Language:

english

File:

PDF, 910 KB

english, 2018

19

Efficacy of Umeclidinium/Vilanterol in Elderly Patients with COPD: A Pooled Analysis of Randomized Controlled Trials

Ray, Riju, Tombs, Lee, Asmus, Michael J., Boucot, Isabelle, Lipson, David A., Compton, Chris, Naya, Ian

Journal:

Year:

2018

Language:

english

File:

PDF, 609 KB

english, 2018

20

Prevention of clinically important deteriorations in COPD with umeclidinium/vilanterol

Singh, Dave, Maleki-Yazdi, M. Reza, Tombs, Lee, Iqbal, Ahmar, Fahy, William A, Naya, Ian

Journal:

International Journal of Chronic Obstructive Pulmonary Disease

Year:

2016

Language:

english

File:

PDF, 1.05 MB

english, 2016

21

Preventing Clinically Important Deterioration of COPD with Addition of Umeclidinium to Inhaled Corticosteroid/Long-Acting β2-Agonist Therapy: An Integrated Post Hoc Analysis

Naya, Ian P., Tombs, Lee, Lipson, David A., Compton, Chris

Journal:

Advances in Therapy

Year:

2018

Language:

english

File:

PDF, 1.01 MB

english, 2018

22

Cost-effectiveness of umeclidinium as add-on to ICS/LABA therapy in COPD: A UK perspective

Driessen, Maurice, Shah, Dhvani, Risebrough, Nancy, Baker, Timothy, Naya, Ian, Briggs, Andrew, Ismaila, Afisi S.

Journal:

Respiratory Medicine

Year:

2018

Language:

english

File:

PDF, 519 KB

english, 2018

23

Long-term outcomes following first short-term clinically important deterioration in COPD

Naya, Ian P., Tombs, Lee, Muellerova, Hana, Compton, Christopher, Jones, Paul W.

Journal:

Respiratory Research

Year:

2018

Language:

english

File:

PDF, 950 KB

english, 2018

24

Preventing clinically important deterioration with single-inhaler triple therapy in COPD

Naya, Ian, Compton, Chris, Ismaila, Afisi S., Birk, Ruby, Brealey, Noushin, Tabberer, Maggie, Zhu, Chang-Qing, Lipson, David A., Criner, Gerard

Journal:

ERJ Open Research

Year:

2018

Language:

english

File:

PDF, 561 KB

english, 2018

25

EFFECT OF AGE ON EFFICACY AND SAFETY OF ONCE-DAILY UMECLIDINIUM IN PATIENTS WITH COPD

SOULE, TEDI, CAVENEY, SCOTT, TOMBS, LEE, NAYA, IAN, BOUCOT, ISABELLE

Journal:

Year:

2018

File:

PDF, 92 KB

2018

26

Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis

Naya, Ian, Tombs, Lee, Lipson, David A., Boucot, Isabelle, Compton, Chris

Journal:

Respiratory Research

Year:

2019

Language:

english

File:

PDF, 998 KB

english, 2019

27

Efficacy and safety of the dual bronchodilator combination umeclidinium/vilanterol in COPD by age and airflow limitation severity: A pooled post hoc analysis of seven clinical trials

Ray, Riju, Tombs, Lee, Naya, Ian, Compton, Chris, Lipson, David A., Boucot, Isabelle

Journal:

Pulmonary Pharmacology & Therapeutics

Year:

2019

Language:

english

File:

PDF, 912 KB

english, 2019

28

Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial

Maltais, François, Bjermer, Leif, Kerwin, Edward M., Jones, Paul W., Watkins, Michael L., Tombs, Lee, Naya, Ian P., Boucot, Isabelle H., Lipson, David A., Compton, Chris, Vahdati-Bolouri, Mitra, Vogel

Journal:

Respiratory Research

Year:

2019

Language:

english

File:

PDF, 1.61 MB

english, 2019

29

Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial

Maltais, François, Bjermer, Leif, Kerwin, Edward M., Jones, Paul W., Watkins, Michael L., Tombs, Lee, Naya, Ian P., Boucot, Isabelle H., Lipson, David A., Compton, Chris, Vahdati-Bolouri, Mitra, Vogel

Journal:

Respiratory Research

Year:

2019

File:

PDF, 1.61 MB

2019

30

Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial

Kerwin, Edward M, Boucot, Isabelle H, Vogelmeier, Claus F, Maltais, Francois, Naya, Ian P, Tombs, Lee, Jones, Paul W, Lipson, David A, Keeley, Tom, Bjermer, Leif

Journal:

Therapeutic Advances in Respiratory Disease

Year:

2020

File:

PDF, 444 KB

2020

31

Measuring disease activity in COPD: is clinically important deterioration the answer?

Singh, Dave, Criner, Gerard J., Naya, Ian, Jones, Paul W., Tombs, Lee, Lipson, David A., Han, MeiLan K.

Journal:

Respiratory Research

Year:

2020

File:

PDF, 1.30 MB

2020

32

Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial

Vogelmeier, Claus F., Kerwin, Edward M., Bjermer, Leif H., Tombs, Lee, Jones, Paul W., Boucot, Isabelle H., Naya, Ian P., Lipson, David A., Compton, Chris, Barnes, Neil, Maltais, FranÃ§ois

Journal:

Therapeutic Advances in Respiratory Disease

Year:

2020

File:

PDF, 536 KB

2020